Signet Jewelers Stock Price, News & Analysis

Signet Jewelers (NYSE:SIG) reported third quarter Fiscal 2026 results for the 13 weeks ended November 1, 2025: sales $1.39B (+3.1% vs Q3 FY25) and same store sales +3.0%. Merchandise AUR rose 7% (Bridal +6%, Fashion +8%). GAAP operating income was $23.9M and adjusted operating income was $32.0M. Adjusted diluted EPS was $0.63 (vs $0.24). Free cash flow improved by more than $100M in the quarter. Year-to-date share repurchases were ~2.8M shares for $178M with ~$545M authorization remaining. Company updated Fiscal 2026 guidance, raising adjusted operating income and EPS ranges.

Signet Jewelers (NYSE: SIG) intends to announce its fiscal 2026 third quarter results at approximately 7:00 a.m. ET on Tuesday, December 2, 2025.

The company will host a conference call at 8:30 a.m. ET the same day with a simultaneous audio webcast available at www.signetjewelers.com.

Dial-in details include North America Toll Free +1 800 549 8228, International +1 646 564 2877 and Conference ID 37876. Registration for the listen-only webcast is available at https://events.q4inc.com/attendee/429305882.

Signet Jewelers (NYSE:SIG), the world's largest diamond jewelry retailer, reported strong Q2 FY2026 results with sales of $1.5 billion, up 3.0% year-over-year. Same-store sales increased 2.0%, driven by a 5% growth in Kay, Zales, and Jared brands. The company achieved adjusted operating income of $85.4 million, a 20% increase, and adjusted EPS of $1.61.

Key metrics include a 9% increase in merchandise AUR, with Bridal up 4% and Fashion up 12%. Gross margin expanded 60 basis points to 38.6%. The company raised its FY2026 guidance, now expecting sales of $6.67-$6.82 billion and adjusted operating income of $445-$515 million.

Signet continued its shareholder returns, repurchasing 446,000 shares for $32 million in Q2 and declaring a quarterly dividend of $0.32 per share.

Signet Jewelers (NYSE:SIG) has scheduled its fiscal 2026 second quarter earnings release and conference call. The company will announce its Q2 results on September 2, 2025 at 7:00 a.m. ET, followed by a conference call at 8:30 a.m. ET.

Investors can access the conference call via toll-free numbers for North America and international locations, or join the simultaneous audio webcast through the company's website.

Signet Jewelers (NYSE:SIG), the world's largest diamond jewelry retailer, has announced three key senior leadership appointments. Julie Yoakum has been named President of Kay Jewelers and Peoples Jewellers, bringing over 30 years of jewelry and apparel industry experience. Stacee Johnson-Williams has been appointed Chief Merchandise Operations and Sourcing Officer to lead central sourcing and core merchandising. Lisa Laich joins as Chief Marketing Officer, bringing extensive brand marketing experience from Crocs and HEYDUDE.

The appointments align with Signet's "Grow Brand Love" strategy, with CEO J.K. Symancyk emphasizing how these experienced leaders will help drive sales growth, enhance merchandising capabilities, and strengthen brand marketing initiatives.

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health solutions, has appointed Gina Drosos to its board of directors, effective June 16. Drosos brings over 30 years of executive leadership experience, most recently serving as CEO of Signet Jewelers from 2017 to 2024, where she led significant digital transformation initiatives. Prior to that, she spent 25 years at Procter & Gamble, culminating as group president of global beauty, skin, cosmetics and personal care. She currently serves on the boards of Foot Locker Inc. and the United States Golf Association. The appointment aligns with IFF's strategy to drive sustainable growth and value creation through experienced leadership in consumer goods, retail, beauty, and healthcare sectors.

Signet Jewelers (NYSE:SIG) reported strong Q1 FY2026 results with sales of $1.5 billion, up 2.0% YoY, and positive same-store sales growth of 2.5%. The company's adjusted diluted EPS reached $1.18, compared to $1.11 in Q1 FY25, while operating income was $48.1 million. Key brands Kay, Zales, and Jared showed sequential comp sales improvement. The company increased its FY26 guidance, now expecting sales of $6.57-$6.80 billion and adjusted EPS of $7.70-$9.38. Signet has been active in capital returns, repurchasing approximately 2.1 million shares for $117.4 million and declaring a quarterly dividend of $0.32 per share. The company's improved performance was driven by refined promotional strategies, inventory management, and higher merchandise margins, with Average Unit Retail increasing by 8.0%.

Signet Jewelers (NYSE: SIG) has scheduled its fiscal 2026 first quarter earnings release and conference call for Tuesday, June 3, 2025. The company will release its financial results at approximately 7:00 a.m. ET, followed by a conference call and simultaneous audio webcast at 8:30 a.m. ET.

Participants can join via phone using toll-free number (+1) 800 549 8228 for North America or (+1) 646 564 2877 for international callers, using Conference ID 90783. A listen-only webcast will also be available through the company's website at www.signetjewelers.com.

Signet Jewelers (SIG), the world's largest diamond jewelry retailer, has achieved a record-breaking fundraising milestone of $10 million in FY2025 for St. Jude Children's Research Hospital, surpassing the previous year's record of $8.75 million. This achievement marks Signet's largest single-year fundraising total in their 26-year partnership.

Customer donations across Signet's brands, including Kay Jewelers, Zales, Jared, and Banter by Piercing Pagoda, grew by an average of 23% during FY25. The company recently announced a new $100 million commitment in October 2023, building upon their cumulative contribution of over $100 million to date.

Fundraising efforts include plush toy sales, customer donations, employee giving campaigns, and proceeds from select product lines. Signet's presence is prominent throughout the St. Jude campus, supporting various facilities including the Patient Registration Area, Solid Tumor Clinic, and Kay Research and Care Center.